TCM Ltd
Incorporated in 1943, TCM Ltd deals in solar panels, healthcare products, and cattle feed products.[1]
- Market Cap ₹ 35.2 Cr.
- Current Price ₹ 47.1
- High / Low ₹ 81.0 / 36.5
- Stock P/E 18.0
- Book Value ₹ 48.2
- Dividend Yield 0.00 %
- ROCE 9.30 %
- ROE 9.20 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.98 times its book value
- Debtor days have improved from 145 to 99.5 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 0.75% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.5.39 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 0.92 | 4.23 | 3.46 | 7.16 | 31.65 | 24.73 | 20.55 | |
| 1.22 | 0.43 | 0.50 | 0.72 | 0.35 | 1.26 | 1.67 | 4.27 | 5.78 | 9.71 | 32.01 | 25.45 | 22.00 | |
| Operating Profit | -1.22 | -0.43 | -0.50 | -0.72 | -0.35 | -0.86 | -0.75 | -0.04 | -2.32 | -2.55 | -0.36 | -0.72 | -1.45 |
| OPM % | -215.00% | -81.52% | -0.95% | -67.05% | -35.61% | -1.14% | -2.91% | -7.06% | |||||
| 0.05 | 0.02 | 0.06 | 0.22 | -0.39 | 0.04 | 1.15 | 1.23 | -1.56 | 0.23 | 0.82 | 4.60 | 5.39 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.05 | 0.01 | 0.12 | 0.01 | 0.01 | 0.01 | 0.27 | 0.15 | 0.60 | 1.73 |
| Depreciation | 0.28 | 0.07 | 0.06 | 0.06 | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.19 | 0.07 | 0.16 | 0.33 |
| Profit before tax | -1.45 | -0.48 | -0.50 | -0.61 | -0.75 | -0.94 | 0.38 | 1.16 | -3.93 | -2.78 | 0.24 | 3.12 | 1.88 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.52% | 0.00% | -0.72% | 16.67% | -0.96% | |
| -1.44 | -0.48 | -0.50 | -0.61 | -0.75 | -0.95 | 0.39 | 0.98 | -3.93 | -2.77 | 0.20 | 3.15 | 1.96 | |
| EPS in Rs | -1.92 | -0.64 | -0.67 | -0.81 | -1.00 | -1.27 | 0.52 | 1.31 | -5.24 | -3.70 | 0.27 | 4.21 | 2.62 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 93% |
| 3 Years: | 93% |
| TTM: | -21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 54% |
| 3 Years: | 58% |
| TTM: | 298% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | 1% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 | 7.48 | 7.48 |
| Reserves | -27.69 | -29.20 | -29.70 | -30.31 | 30.33 | 29.02 | 29.16 | 30.14 | 23.73 | 26.90 | 27.10 | 30.36 | 28.57 |
| 24.28 | 24.69 | 25.15 | 6.30 | 5.38 | 5.38 | 5.64 | 5.83 | 6.02 | 1.08 | 0.27 | 11.22 | 20.63 | |
| 7.26 | 7.28 | 7.29 | 26.73 | 25.74 | 31.35 | 27.23 | 29.14 | 30.19 | 37.04 | 54.92 | 34.08 | 33.69 | |
| Total Liabilities | 7.25 | 6.17 | 6.14 | 6.12 | 64.85 | 69.15 | 65.43 | 68.51 | 63.34 | 72.50 | 89.77 | 83.14 | 90.37 |
| 2.49 | 1.39 | 1.33 | 1.26 | 58.01 | 58.01 | 58.01 | 58.42 | 54.70 | 35.12 | 16.85 | 13.59 | 13.51 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.05 |
| Investments | 0.24 | 0.24 | 0.24 | 0.24 | 0.80 | 0.44 | 0.19 | 0.19 | 0.17 | 0.52 | 0.91 | 1.62 | 1.83 |
| 4.52 | 4.54 | 4.57 | 4.62 | 6.04 | 10.70 | 7.23 | 9.90 | 8.47 | 36.86 | 72.01 | 67.93 | 72.98 | |
| Total Assets | 7.25 | 6.17 | 6.14 | 6.12 | 64.85 | 69.15 | 65.43 | 68.51 | 63.34 | 72.50 | 89.77 | 83.14 | 90.37 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.31 | -0.40 | -0.43 | -0.72 | -4.39 | -1.63 | -0.56 | -0.11 | -2.79 | -9.56 | 3.74 | -10.79 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 3.98 | -0.01 | -0.01 | -0.04 | 2.81 | 4.39 | -2.78 | 0.53 | |
| 0.32 | 0.41 | 0.47 | 0.83 | 0.15 | 5.32 | -3.14 | 0.18 | 0.20 | 4.99 | -0.94 | 10.37 | |
| Net Cash Flow | 0.01 | 0.01 | 0.03 | 0.10 | -0.25 | 3.68 | -3.70 | 0.03 | 0.22 | -0.18 | 0.01 | 0.11 |
| Free Cash Flow | -0.31 | -0.40 | -0.43 | -0.72 | -0.41 | -1.63 | -0.56 | -0.54 | 0.90 | -11.05 | 3.22 | -11.05 |
| CFO/OP | 25% | 93% | 86% | 100% | 1,254% | 190% | 75% | 275% | 120% | 373% | -1,114% | 1,519% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1,377.88 | 706.20 | 217.45 | 195.16 | 238.07 | 97.45 | 99.48 | |||||
| Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.13 | 480.07 | 570.68 | |||||
| Days Payable | 2,581.07 | 1,914.85 | 747.47 | 65.98 | 71.72 | 42.86 | 47.36 | |||||
| Cash Conversion Cycle | 274.18 | -360.73 | -62.13 | 321.51 | 435.48 | 534.66 | 622.80 | |||||
| Working Capital Days | -10,986.50 | -3,209.62 | -812.84 | -1,301.76 | -474.60 | 97.45 | -53.72 | |||||
| ROCE % | -268.52% | -1.30% | -2.13% | 1.03% | 2.04% | -4.72% | -7.32% | 1.11% | 9.30% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number |
|
|||||||||
| Revenue Contribution: Solar Division (Installation & Trading) ₹ Lakhs |
||||||||||
| Revenue Contribution: Education Division (Subsidiary) ₹ Lakhs |
||||||||||
| Revenue Contribution: Cattle Feed (Manufactured) ₹ Lakhs |
||||||||||
| Real Estate - Land Area for Development Acres |
||||||||||
| Solar Power Plant Capacity Work Orders (Extracted from announcements) KWp |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Disclosure/Declaration Under Regulation 31(4) Of SEBI(SAST) Regulations 2011 For The FY Ended 31St March 2026 From The Promoters Of The Company
2d - Promoters filed FY2025-26 Regulation 31(4) declaration confirming no share encumbrance.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
2d - TCM Limited confirms it is not a Large Corporate under SEBI borrowing disclosure norms.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
17 Apr - Confirmation Certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ending 31st March 2026 received from our RTA, M/s Cameo Corporate Services Ltd. …
-
Closure of Trading Window
27 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited results for quarter ended 31-Mar-2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, 17Th February 2026
17 Feb - Board approved Rs1.37 crore term loan from Indian Bank, 9.6% variable, secured by Maradu Hi-Lite property.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
TCML is in the business of setting up and commissioning of Solar Power plants, trading
of medical diagnostic products, manufacture of cattle feed and real estate business.